Delivery Order SPE2DB20D3101-SPE2DB25FRSH9
Award Date 8/12/25
Potential Completion Date 8/13/25
Potential Value $1.8K
Federal Agency
Awardee
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $1,620.00 to AmerisourceBergen Drug Corp for the supply of Mesalamine ER 0.375 gram capsules (120-count unit). The contract employs firm fixed pricing with no set-aside designation, indicating competitive award. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, will perform the work at its corporate office location. The award was executed on July 24, 2025, with an ultimate completion date of July 25, 2025,...
- The Defense Logistics Agency awarded a $1,481.48 firm fixed price delivery order to AmerisourceBergen Drug Corp on July 28, 2025, for the supply of Mesalamine ER 0.375 gram capsules (120 count). This non-competitive delivery order is expected to be completed by July 29, 2025, with performance taking place at the vendor's corporate office location in Conshohocken, Pennsylvania. The delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop...
- The Defense Logistics Agency awarded a $7,361.02 delivery order to AmerisourceBergen Drug Corp on July 29, 2025, for the supply of Mesalamine 400 mg capsules (180-count units). This non-set-aside contract features firm fixed pricing and is scheduled for completion by July 30, 2025, with performance taking place at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The delivery order represents a discrete purchase under AmerisourceBergen's broader federal...
- AmerisourceBergen Drug Corp was awarded a delivery order by the Defense Logistics Agency (DLA) on August 13, 2025, for the supply of Mesalamine DR 400 mg capsules (180-count units) with a ceiling value of $1,952.10. The contract carries a firm fixed price structure with no set-aside designation, indicating it was competitively awarded. Performance will be executed from the vendor's facility in Conshohocken, Pennsylvania, with an ultimate completion date of August 14, 2025. This delivery order...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $2,739.99 to AmerisourceBergen Drug Corp for the supply of Mesalamine DR 1.2 GM tablets (120-count package) on August 5, 2025, with completion targeted for August 6, 2025. This contract utilizes firm fixed-price pricing with no set-aside designation, indicating competitive procurement. The award represents a child delivery order under AmerisourceBergen Drug Corp's larger Indefinite Delivery Contract (IDC) with DLA Troop...
- The Defense Logistics Agency awarded a $17,412.86 delivery order to AmerisourceBergen Drug Corp for 180 tablets of Mesalamine 800 mg delayed-release medication, with an ultimate completion date of July 29, 2025. This is a firm fixed-price, competitively awarded contract with no set-aside designation. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor serving as a critical vendor for federal medical procurement, particularly...
- The Defense Logistics Agency awarded a delivery order valued at $3,841.26 to AmerisourceBergen Drug Corp for Mesalamine ER 0.375 gram capsules (120-count supply). This is a firm fixed price contract with no set-aside designation, awarded on August 14, 2025, with an ultimate completion date of August 15, 2025. The order will be fulfilled from AmerisourceBergen's Conshohocken, Pennsylvania location. Mesalamine is a gastrointestinal anti-inflammatory medication used to treat conditions such as...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 28, 2025, for the supply of Mesalamine DR 1.2 GM tablets (120-count units) under a firm fixed-price contract valued at $1,076.10. This non-set-aside award is part of a child contract under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a $1 billion vehicle running through December 2026 that serves as the primary global pharmaceutical support mechanism for...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 5, 2025, for the supply of Mesalamine DR 1.2 GM tablets (120-count) with a ceiling value of $1,512.73. This firm fixed-price delivery order, which is non-set-aside and competitively awarded, will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania, with an ultimate completion date of August 6, 2025. The delivery order falls under AmerisourceBergen's larger...
- AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, has been awarded a delivery order by the Defense Logistics Agency for Mesalamine DR 1.2 GM tablets (120-count bottles) with a ceiling value of $4,353.25. The contract employs firm fixed-price pricing and is scheduled for completion by July 29, 2025. This award was competitively procured without a set-aside designation, demonstrating AmerisourceBergen's ability to compete in open federal pharmaceutical procurement. The...